{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:58:20Z","timestamp":1740146300093,"version":"3.37.3"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T00:00:00Z","timestamp":1512950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0188314","type":"journal-article","created":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T13:29:44Z","timestamp":1512998984000},"page":"e0188314","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Transcriptional profiling of PBMCs unravels B cell mediated immunopathogenic imprints of HCV vasculitis"],"prefix":"10.1371","volume":"12","author":[{"given":"Emily","family":"Comstock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheol-Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Emmanuel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Sneller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhawna","family":"Poonia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7471-0812","authenticated-orcid":true,"given":"Shyamasundaran","family":"Kottilil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,12,11]]},"reference":[{"key":"ref1","first-page":"294","article-title":"Hepatitis C virus infection and coinfection with human immunodeficiency virus: challenges and advancements in management","volume":"306","author":"C Hadigan","year":"2011"},{"year":"2016","key":"ref2","article-title":"Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study"},{"key":"ref3","first-page":"161","article-title":"An overview of HCV molecular biology, replication and immune responses","volume":"8","author":"UA Ashfaq","year":"2011"},{"key":"ref4","first-page":"2082","article-title":"National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C 2002 (June 10\u201312, 2002)","volume":"123","year":"2002"},{"issue":"8","key":"ref5","first-page":"3352","article-title":"Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome","volume":"124","author":"EG Meissner","year":"2014"},{"key":"ref6","first-page":"1017","article-title":"Manifestations of chronic hepatitis C virus infection beyond the liver","volume":"8","author":"IM Jacobson","year":"2010"},{"key":"ref7","first-page":"65","article-title":"Extrahepatic manifestations of chronic HCV infection","volume":"16","author":"A Galossi","year":"2007"},{"key":"ref8","first-page":"897","article-title":"Cryoglobulinemia related to hepatitis C virus infection","volume":"52","author":"MP Dore","year":"2007"},{"key":"ref9","first-page":"399","article-title":"Hepatitis C virus and mixed cryoglobulinaemia","volume":"23","author":"C Ferri","year":"1993"},{"key":"ref10","first-page":"2917","article-title":"Involvement of chemokines and type 1 cytokines in the pathogenesis of hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy","volume":"52","author":"D Saadoun","year":"2005"},{"key":"ref11","first-page":"1145","article-title":"Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: A prospective, controlled, open-label, cohort study","volume":"61","author":"L Gragnani","year":"2015"},{"issue":"9","key":"ref12","first-page":"950","article-title":"Cryoglobulinemia vasculitis","volume":"128","author":"P Cacoub","year":"2015"},{"key":"ref13","first-page":"54","article-title":"Cryoglobulinemic vasculitis","volume":"18","author":"C Ferri","year":"2006"},{"issue":"2","key":"ref14","first-page":"231","article-title":"B cell activating factor (BAFF) in the natural history of chronic hepatitis C virus liver disease and mixed cryoglobulinaemia","volume":"170","author":"G Lake-Bakaar","year":"2012"},{"issue":"20","key":"ref15","first-page":"5425","article-title":"Clonal B cells in patients with hepatitis C virus\u2013associated mixed cryoglobulinemia contain an expanded anergic CD21<sup>low<\/sup> B-cell subset","volume":"117","author":"ED Charles","year":"2011"},{"key":"ref16","first-page":"2507","article-title":"Cryoglobulinemic vasculitis","volume":"42","author":"P Lamprecht","year":"1999"},{"key":"ref17","first-page":"248","article-title":"Hepatitis C-associated mixed cryoglobulinemic vasculitis induces differential gene expression in peripheral mononuclear cells","volume":"5","author":"S Sidharthan","year":"2014"},{"key":"ref18","first-page":"S39","article-title":"HCV infection: pathogenesis, clinical manifestations and therapy","volume":"26","author":"A Antonelli","year":"2008"},{"key":"ref19","first-page":"23","article-title":"Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis","volume":"20","author":"D Saadoun","year":"2008"},{"key":"ref20","first-page":"835","article-title":"A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis","volume":"64","author":"MC Sneller","year":"2012"},{"key":"ref21","first-page":"2252","article-title":"Rituximab for the treatment of type II mixed cryoglobulinemia","volume":"46","author":"F Zaja","year":"2002"},{"key":"ref22","first-page":"1","article-title":"Combined treatment with antiviral therapy and rituximab in patients with mixed cryoglobulinemia: review of the literature and report of a case using direct antiviral agents-based antihepatitis C virus therapy","volume":"816424","author":"T Urraro","year":"2015"},{"key":"ref23","first-page":"1157","article-title":"Rituximab for the treatment of type II mixed cryoglobulinemia","volume":"84","author":"F Zaja","year":"1999"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1084\/jem.189.11.1747","article-title":"BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth","volume":"189","author":"P Schneider","year":"1999","journal-title":"J. Exp. Med."},{"key":"ref25","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/ni829","article-title":"DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL","volume":"3","author":"M.B. Litinskiy","year":"2002","journal-title":"Nat. Immunol."},{"key":"ref26","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1182\/blood.V97.1.198","article-title":"Synthesis and release of B-lymphocyte stimulator from myeloid cells","volume":"97","author":"B Nardelli","year":"2001","journal-title":"Blood"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/path.1533","article-title":"Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjogren\u2019s syndrome","volume":"202","author":"F Lavie","year":"2008","journal-title":"J. Pathol."},{"key":"ref28","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1084\/jem.20021343","article-title":"G-CSF-stimulated neutrophils are a prominent source of functional BLyS","volume":"197","author":"P Scapini","year":"2003","journal-title":"J. Exp. Med."},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.4049\/jimmunol.174.5.3015","article-title":"Enhanced apoptotic cell clearance capacity and B cell survival factor production by IL\u201310\u2013activated macrophages: implications for Burkitt\u2019s lymphoma","volume":"174","author":"C.A. Ogden","year":"2005","journal-title":"J. Immunol."},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1182\/blood-2007-09-110874","article-title":"TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts","volume":"111","author":"C Bossen","year":"2008","journal-title":"Blood"},{"issue":"12","key":"ref31","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1002\/art.30613","article-title":"A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus","volume":"63","author":"R Furie","year":"2011","journal-title":"Arthritis Rheum."},{"key":"ref32","first-page":"833","article-title":"Triple antiviral therapy in hepatitis C virus infection with or without mixed cryoglobulinaemia: a prospective, controlled pilot study","volume":"46","author":"L Gragnani","year":"2014"},{"key":"ref33","first-page":"34","article-title":"Human immunodeficiency virus and hepatitis C infections induce distinct immunologic imprints in peripheral mononuclear cells","volume":"50","author":"S Kottilil","year":"2009"},{"key":"ref34","first-page":"544","article-title":"Persistently elevated abnormal B-cell subpopulations and anti-core antibodies in patients co-infected with HIV\/HCV who relapse","volume":"87","author":"A Kohli","year":"2015"},{"key":"ref35","first-page":"38","article-title":"Resistance to rituximab therapy and local BAFF overexpression in Sj\u00f6gren\u2019s syndrome-related myoepithelial sialadenitis and low-grade parotid B-cell lymphoma","volume":"2","author":"L Quartuccio","year":"2008"},{"issue":"3","key":"ref36","first-page":"326","article-title":"Rituximab plus Peg-interferon-alpha\/ribavirin compared with Peg-interferon-alpha\/ribavirin in hepatitis C-related mixed cryoglobulinemia","volume":"22","author":"Saadoun","year":"2010"},{"issue":"3","key":"ref37","first-page":"343","article-title":"Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study","volume":"116","author":"F Dammacco","year":"2010"},{"key":"ref38","first-page":"1431","article-title":"Rituximab combined with Peg-interferon-ribavirin in refractory hepatitis C virus-associated cryoglobulinaemia vasculitis","volume":"67","author":"D Saadoun","year":"2008"},{"key":"ref39","first-page":"5571","article-title":"B cells in early and chronic HIV infection: evidence for preservation of immune function associated with early initiation of antiretroviral therapy","volume":"116","author":"S Moir","year":"2010"},{"issue":"3","key":"ref40","first-page":"335","article-title":"Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease","volume":"116","author":"A Petrarca","year":"2010"},{"issue":"11","key":"ref41","first-page":"1035","article-title":"Therapy for hepatitis C virus\u2013related cryoglobulinemic vasculitis","volume":"369","author":"F Dammacco","year":"2013"},{"issue":"1","key":"ref42","first-page":"37","article-title":"-Lymphocyte stimulator (BLyS) up-regulation in mixed cryoglobulinaemia syndrome and hepatitis-C virus infection","volume":"46","author":"M Fabris","year":"2007","journal-title":"B"},{"issue":"1","key":"ref43","first-page":"65","article-title":"Hepatitis C virus-associated B-cell proliferation\u2014the role of serum B lymphocyte stimulator (BLyS\/BAFF)","volume":"46","author":"D S\u00e8ne","year":"2007"},{"key":"ref44","first-page":"723","article-title":"Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: relationships with B cell depletion, circulating antibodies, and clinical relapse","volume":"54","author":"G Cambridge","year":"2006"},{"issue":"1","key":"ref45","first-page":"65","article-title":"Hepatitis C virus-associated B-cell proliferation-the role of serum B lymphocyte stimulator (BlyS\/BAFF)","volume":"46","author":"D Sene","year":"2007"},{"issue":"5","key":"ref46","first-page":"1446","article-title":"Genetic determinants in hepatitis C virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fc\u03b3 receptors","volume":"63","author":"L. Gragnani","year":"2011"},{"key":"ref47","first-page":"48","article-title":"Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: Results of multicenter cohort study and review of the literature","volume":"11","author":"C Ferri","year":"2011"},{"key":"ref48","first-page":"2943","article-title":"Association between persistent lymphatic infection by hepatitis C virus after antiviral treatment and mixed cryoglobulinemia","volume":"111","author":"C Giannini","year":"2008"},{"issue":"3","key":"ref49","first-page":"337","article-title":"The B lymphocyte stimulator receptor-ligand system in hepatitis C virus-induced B cell clonal disorders","volume":"68","author":"DA Landau","year":"2009"},{"issue":"1","key":"ref50","first-page":"37","article-title":"B-Lymphocyte stimulator up-regulation (BLyS) in mixed cryoglobulinemia syndrome and hepatitis C virus infection","volume":"46","author":"M Fabris","year":"2007"},{"key":"ref51","first-page":"1145","article-title":"Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: A prospective, controlled, open-label, cohort study","volume":"61","author":"L Gragnani","year":"2015"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0188314","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T07:14:41Z","timestamp":1540278881000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0188314"}},"subtitle":[],"editor":[{"given":"Ranjit","family":"Ray","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,12,11]]},"references-count":51,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,12,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0188314","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2017,12,11]]}}}